2020, Número 11
Actualización en dermatitis atópica: líneas de tratamiento
Idioma: Español
Referencias bibliográficas: 25
Paginas: 1-12
Archivo PDF: 256.68 Kb.
RESUMEN
La dermatitis atópica es la dermatosis inflamatoria más frecuente, con un pico de prevalencia en la niñez temprana y con mayor porcentaje de afectación en países industrializados. Entre las principales características de este trastorno crónico y/o recidivante se destacan, el prurito, la dermatitis eccematosa, el compromiso facial y de regiones extensoras en la niñez temprana, mientras que el eccema y liquenificación en pliegues es más usual en niños y adultos. En los últimos años ha habido un avance en el conocimiento de la patogenia, centrada en la vía Th2, pero con una participación significativa de la vía Th22 y de los ejes Th1 y Th17, de la disfunción de la barrera epidérmica, el prurito y la señalización JAK/STAT, este progreso ha condicionado innovaciones en los tratamientos tópicos y sistémicos.REFERENCIAS (EN ESTE ARTÍCULO)
Lara-Corrales I, Bergman J, Landells I, Ramien M, Lansang P. Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section I: Overview of Pediatric Atopic Dermatitis. Journal of Cutaneous Medicine and Surgery [Internet]. 2019 [cited 9 April 2020];23(5_suppl):3S-11S. https://doi.org/10.1177/1203475419882049
Chu H, Park K, Kim S, Lee J, Park J, Lee K et al. Allergen‐specific immunotherapy for patients with atopic dermatitis sensitized to animal dander. Immunity, Inflammation and Disease [Internet]. 2020 [cited 9 April 2020];8(1):1-123. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/iid3.291
Lauritano D, Ronconi G, Caraffa A, Enrica Gallenga C, Kritas S, Di Emidio P et al. New aspect of allergic contact dermatitis, an inflammatory skin disorder mediated by mast cells: Can IL-38 help?. Medical Hypotheses [Internet]. 2020 [cited 9 April 2020];139:109687. https://doi.org/10.1016/j.mehy.2020.109687
Leonard A, Wang J, Yu L, Liu H, Estrada Y, Greenlees L et al. Atopic Dermatitis Endotypes Based on Allergen Sensitization, Reactivity to Staphylococcus aureus Antigens, and Underlying Systemic Inflammation. The Journal of Allergy and Clinical Immunology: In Practice [Internet]. 2020 [cited 8 April 2020];8(1):236-247.e3. https://doi.org/10.1016/j.jaip.2019.08.013
El Hachem M, Di Mauro G, Rotunno R, Giancristoforo S, De Ranieri C, Carlevaris C et al. Pruritus in pediatric patients with atopic dermatitis: a multidisciplinary approach - summary document from an Italian expert group. Italian Journal of Pediatrics [Internet]. 2020 [cited 9 April 2020];46(1). https://doi.org/10.1186/s13052-020-0777-9
Hon K, Lam P, Ng W, Kung J, Cheng N, Lin Z et al. Age, sex, and disease status as determinants of skin hydration and transepidermal water loss among children with and without eczema. Hong Kong Medical Journal [Internet]. 2020 [cited 6 April 2020];26(1):19-26. Available from: https://www.hkmj.org/abstracts/v26n1/19.htm
Davidson W, Leung D, Beck L, Berin C, Boguniewicz M, Busse W et al. Report from the National Institute of Allergy and Infectious Diseases workshop on "Atopic dermatitis and the atopic march: Mechanisms and interventions". Journal of Allergy and Clinical Immunology [Internet]. 2019 [cited 8 April 2020];143(3):894- 913. https://doi.org/10.1016/j.jaci.2019.01.003
Chidwick K, Busingye D, Pollack A, Osman R, Yoo J, Blogg S et al. Prevalence, incidence and management of atopic dermatitis in Australian general practice using routinely collected data from MedicineInsight. Australasian Journal of Dermatology [Internet]. 2020 [cited 9 April 2020];. https://doi.org/10.1111/ajd.13268
Sánchez J, Sánchez M, Macías-Weinmann A, Barreto B, Ensina L, Uriarte-Obando S et al. Systematic review about 10 interventions in dermatitis. A document from the Latin American Society of Allergy, Asthma, and Immunology. Revista Alergia México [Internet]. 2019 [cited 10 April 2020];66(4):426. https://doi.org/10.29262/ram.v66i4.636
Ferrucci S, Casazza G, Angileri L, Tavecchio S, Germiniasi F, Berti E et al. Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience. Journal of Clinical Medicine [Internet]. 2020 [cited 9 April 2020];9(3):791. https://doi.org/10.3390/jcm9030791